Literature DB >> 9477120

Regulation of hematopoiesis by microvascular endothelium.

S Rafii1, R Mohle, F Shapiro, B M Frey, M A Moore.   

Abstract

The bone marrow microenvironment is a complex three dimensional structure where hematopoietic stem cells proliferate, mature, migrate into the sinusoidal space, and enter the circulation in an exquisitely regulated fashion. Stromal cells within the BM microenvironment provide a suitable environment for self-renewal, proliferation and differentiation of hematopoietic stem cells. Within the hematopoietic microenvironment, whether it is embryonic yolk sac, fetal liver, or adult bone marrow, microvascular endothelium not only acts as a gatekeeper controlling the trafficking and homing of hematopoietic progenitors, but also provides cellular contact and secretes cytokines that allows for the preservation of the steady state hematopoiesis. Recently, homogenous monolayers of bone marrow endothelial cells (BMEC) have been isolated and cultivated in tissue culture. Long-term coculture studies have shown that BMEC monolayers are unique type of endothelium and can support long-term proliferation of hematopoietic progenitor cells particularly megakaryocytic and myeloid progenitor cells by constitutive elaboration of lineage-specific cytokines such as G-CSF, GM-CSF, M-CSF, Kit-ligand, IL6, FLK-2 ligand, and leukemia inhibitory factor. Direct cellular contact between hematopoietic progenitor cells and BMEC monolayers through specific adhesion molecules including beta1, beta2 integrins and selectins play a critical role in trafficking and possibly proliferation of hematopoietic stem cells. Dysfunction of microvascular endothelial cells within the hematopoietic microenvironment may result in stem cell disorders and progression to aplastic anemias, and contribute to graft failure during bone marrow transplantation. Further studies on the role of microvascular endothelium in the regulation of hematopoietic stem cell homing and proliferation may enhance our understanding of the pathophysiology of stem cell and leukemic disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9477120     DOI: 10.3109/10428199709058305

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  34 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 2.  Adhesion receptors involved in HSC and early-B cell interactions with bone marrow microenvironment.

Authors:  Maria De Grandis; Anne-Catherine Lhoumeau; Stéphane J C Mancini; Michel Aurrand-Lions
Journal:  Cell Mol Life Sci       Date:  2016-02       Impact factor: 9.261

3.  Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells.

Authors:  Xue-Song Jiang; Chou Chai; Yue Zhang; Ren-Xi Zhuo; Hai-Quan Mao; Kam W Leong
Journal:  Biomaterials       Date:  2006-01-10       Impact factor: 12.479

4.  Tie2 activation contributes to hemangiogenic regeneration after myelosuppression.

Authors:  Hans-Georg Kopp; Scott T Avecilla; Andrea T Hooper; Sergey V Shmelkov; Carlos A Ramos; Fan Zhang; Shahin Rafii
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

Review 5.  T and B lymphocyte differentiation from hematopoietic stem cell.

Authors:  Anne Y Lai; Motonari Kondo
Journal:  Semin Immunol       Date:  2008-06-25       Impact factor: 11.130

6.  Open the gates: vascular neurocrine signaling mobilizes hematopoietic stem and progenitor cells.

Authors:  Tomer Itkin; Jesús María Gómez-Salinero; Shahin Rafii
Journal:  J Clin Invest       Date:  2017-11-13       Impact factor: 14.808

Review 7.  Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy.

Authors:  Paolo Anderlini; Richard Champlin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 8.  Hematopoietic Stem Cell and Its Bone Marrow Niche.

Authors:  V W C Yu; D T Scadden
Journal:  Curr Top Dev Biol       Date:  2016-03-21       Impact factor: 4.897

Review 9.  Megakaryocytes, malignancy and bone marrow vascular niches.

Authors:  B Psaila; D Lyden; I Roberts
Journal:  J Thromb Haemost       Date:  2012-02       Impact factor: 5.824

10.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.